Agilent BioTek Cytation C10 Confocal Imaging Reader Enhanced with Innovative Water Immersion Technology
04 Dezembro 2023 - 10:00AM
Business Wire
Empowering researchers with superior imaging performance for
cutting-edge live-cell and three-dimensional applications
Agilent Technologies Inc. (NYSE: A) today announced the addition
of water immersion and new confocal spinning disk technology to the
BioTek Cytation C10 confocal imaging reader. These features improve
image quality and results by reducing deleterious effects on
live-cell samples and enhancing clarity for thicker samples such as
tissues and 3-D spheroids.
In light microscopy, water immersion technology automatically
and consistently places a layer of water between the objective lens
and the sample. The higher refractive index of water, as compared
to air, effectively increases the numerical aperture of the
objective lens; this reduces z-axis distortion, resulting in higher
image quality and a more true-to-life representation of thick and
three-dimensional cell models. Water immersion also benefits
researchers who are increasingly turning to physiologically
relevant live-cell (as opposed to fixed-cell) applications by
reducing exposure times, thus lowering the phototoxic effects
traditionally associated with these experiments.
Spinning disk confocal technology improves microscopic images by
blocking out-of-focus light from reaching the image sensor. The new
deep-sectioning spinning disk (DSD), now available as an option on
the Cytation C10, allows researchers to look deeper into thick
samples with less out-of-focus blur. The clearer images that result
are particularly beneficial in quantitative analysis
applications.
“The additions of water immersion objectives and a
deep-sectioning confocal spinning disk to the Cytation C10 add
significant new capabilities for researchers requiring the best
imaging performance for live-cell and 3D applications,” stated
Caleb Foster, associate vice president of marketing in Agilent’s
Cell Analysis Division. “As the demands continue to grow for more
complex physiologically relevant live-cell models, the Cytation C10
will be an invaluable and transformative research tool to support
these imaging application areas.”
Designed as an affordable, high-performance confocal microscopy
system, the Cytation C10 employs high-quality components, including
a Hamamatsu scientific CMOS (sCMOS) camera, Olympus objectives, and
laser-based illumination. Onboard environmental controls, widefield
fluorescence, brightfield, and phase contrast optics further
enhance the system’s capabilities. Additionally, integrating it
with the Agilent BioTek BioSpa 8 automated incubator enables
efficient multi-plate live-cell analysis.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in
analytical and clinical laboratory technologies, delivering
insights and innovation that help our customers bring great science
to life. Agilent’s full range of solutions includes instruments,
software, services, and expertise that provide trusted answers to
our customers' most challenging questions. The company generated
revenue of $6.85 billion in fiscal 2022 and employs 18,000 people
worldwide. Information about Agilent is available at
www.agilent.com. To receive the latest Agilent news, please
subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and
Facebook.
.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231204043759/en/
Naomi Goumillout Agilent Technologies +1.978.314.1862
naomi.goumillout@agilent.com
Agilent Technologies (NYSE:A)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Agilent Technologies (NYSE:A)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024